奥美罗斯制药 OMER
$16.92 −$0.15 (-0.88%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $17.00 +0.47%
开盘$17.26
昨收$17.07
当日区间$16.64 – $17.35
成交量1.02M
市值$1.22B
市盈率（TTM）9.8
股息率–
财报
财报日平均波动±14.9%近16次财报
收涨次数9 / 1656% 的概率
最佳反应+65.9%
最差反应-18.6%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 12 Aug 2026 | After Market | ±12.0% | +26.55% | 超出定价预期 |
| 2026/Q1 | 13 May 2026 | After Market | ±9.2% | -7.65% | 符合区间 |
| 2025/Q4 | 31 Mar 2026 | After Market | ±14.7% | +14.39% | 符合区间 |
| 2025/Q3 | 13 Nov 2025 | After Market | ±13.4% | +25.32% | 超出定价预期 |
| 2025/Q2 | 14 Aug 2025 | After Market | ±32.0% | +7.04% | 符合区间 |
| 2025/Q1 | 15 May 2025 | After Market | ±29.4% | -18.61% | 符合区间 |
| 2024/Q4 | 31 Mar 2025 | After Market | ±22.4% | -3.77% | 符合区间 |
| 2024/Q3 | 13 Nov 2024 | After Market | ±23.9% | +65.87% | 超出定价预期 |
| 2024/Q2 | 7 Aug 2024 | After Market | ±34.3% | -5.78% | 符合区间 |
| 2023/Q3 | 9 Nov 2023 | After Market | ±29.4% | -0.79% | 符合区间 |
| 2023/Q2 | 9 Aug 2023 | Pre Market | ±39.4% | +1.88% | 符合区间 |
| 2023/Q1 | 9 May 2023 | None | ±21.8% | +21.20% | 符合区间 |
| 2022/Q4 | 13 Mar 2023 | After Market | ±17.4% | +9.28% | 符合区间 |
| 2022/Q3 | 9 Nov 2022 | After Market | ±28.2% | -5.85% | 符合区间 |
| 2022/Q2 | 9 Aug 2022 | After Market | ±33.0% | +20.32% | 符合区间 |
| 2022/Q1 | 10 May 2022 | None | ±40.4% | -4.04% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q2, ended Jun 2026
营收$28.53M
营业利润$74,000.00+100.2% YoY
净利润$13.23M+152.0% YoY
摊薄每股收益$0.15+134.9% YoY
自由现金流$4.10M+118.7% YoY
经营现金流$4.15M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率97.2%
营业利润率-189.5%
净利率324.9%
资产收益率51.2%
流动比率1.95
负债/资产比率117.9%
现金及投资$131.95M
总负债$132.41M
净现金（净负债）-$453,000.00
暂无评论——快来第一个聊聊 OMER。